Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Drug:  tirapazamine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0003, S0003, NCT00006484

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SANOFI-EFC3675, NCT00017459

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC4690, SR259075, NCT00094081

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC5512, SR259075, NCT00174837

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00591, CAN-NCIC-GOG-0219, CDR0000455555, GOG-0219, U10CA027469, NCT00262821

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-94082, NCI-V94-0542

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-96062, SANOFI-EFC3031, NCI-G97-1235

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: RTOG-9417, RTOG-94-17

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-94114A1, NCI-V95-0659

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 17
Sponsor: NCI, Other
Protocol IDs: IRB-12503, CA67166, NCI-T94-0119O, CDR0000064752, SQL 72951, SUMC-OP-003, T94-0119, NCT00002774

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: GOG-0146M, NCT00020696

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 21 at time of initial diagnosis
Sponsor: NCI
Protocol IDs: NCI-2012-01864, ARST0121, U10CA098543, CDR0000068954, COG-ARST0121, NCT00025363

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03042, U10CA032102, S0222, SWOG-S0222, NCT00066742

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066358, SWOG-S9717, U10CA032102, S9717, NCT00003369

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-01837, POG-9675, CDR0000066219, NCT00003288

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 99139, U01CA062505, P30CA033572, CHNMC-PHI-22, CHNMC-IRB-99139, NCI-T99-0068, CDR0000067685, T99-0068, NCT00005078

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068318, U10CA032102, S0004, SWOG-S0004, NCT00006487

18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCC-PHI-31, CHNMC-PHI-31, NCI-571, NCT00033410, 571

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: PMCC-2004/354, 5485, NCI-5485, NCT00098995
New Search